Modelled mean (SEM) observed forced vital capacity (FVC) volume change from baseline (mL) over time by dose intensity (>90%, ≤90%), based on actual dose.

Slides:

Advertisements

Similar presentations

OFEV® (nintedanib) efficacy

Advertisements

Pulmonary response in sarcoidosis

Vitamin D3 increased ASL antimicrobial activity.

Filming: 15th of Febuary 2016, London, UK

Longitudinal change in FVC, DLCO and RBC:TP.

Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease Martin et al. Am J Nephrol 2017;45: (DOI:

The significantly different metabolites between the systemic inflammatory response syndrome SIRS (n=15) and sepsis (n=35) groups (A); the sepsis (n=10)

This patient with a malignant pleural effusion was treated with an indwelling pleural catheter (IPC). This patient with a malignant pleural effusion was.

Patients included in linear extrapolation and observed/last observation carried forward analyses at week 48. Patients who were rescued or discontinued.

Long-term Data: INPULSIS®-ON

The relationship between body mass index (BMI) and per cent predicted forced expiratory volume in 1 s (FEV1) (A) and per cent predicted forced vital capacity.

Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.

Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3. Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3.

A) Forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ratio as a function of age showing individuals with FEV1/FVC ratio less than the.

Change from baseline following beclomethasone/formoterol and placebo in a) platelet–monocyte aggregate formation, b) P-selectin expression and c) platelet.

For most patients with asthma airway response becomes flatter after 1000 µg of inhaled corticosteroid, but systemic activity (measured by serum cortisol.

Variable life adjusted display (VLAD chart) showing observed versus expected mortability with cumulative lives lost below the x-axis and cumulative lives.

ASAS 20/40 response rates, and mean change from baseline in BASDAI through week 156* of treatment. *For patients who discontinued, the end of treatment.

Change from baseline in (A) E-RS total score and (B) E-RS cough and sputum domain score over the study period in ATTAIN and the active-comparator study.

(A) Refined profile principal component analysis loading weights plot was used to derive insight into possible association of biomarkers. (A) Refined profile.

Volume 154, Issue 5, Pages (November 2018)

Change from baseline in the severity of night-time cough and the frequency of night-time sputum production at week 12 in ACCORD COPD I.17 Data are reported.

Subgroup analysis. Subgroup analysis. Effect of vitamin D supplementation on outcome variables in subgroups defined by baseline levels of the respective.

Clinical and patient-reported outcomes for patients randomised to CZP 200 mg Q2W and CZP 400 mg Q4W to week 96. Clinical and patient-reported outcomes.

Study design (A) and subject disposition (B).

Incidence of choking in London, UK, by gender per 1000 population by age group. Incidence of choking in London, UK, by gender per 1000 population by age.

Peripheral blood eosinophil levels based on a threshold of (A) 150 cells/μL, patients not randomised to inhaled corticosteroids (ICS)-containing treatment.

Change from baseline in the severity of morning cough and severity of difficulty bringing up phlegm in the morning over the study period in the active-comparator.

Patient case study 2—fibrotic uILD in the setting of IPAF

Prevalence of chronic obstructive pulmonary disease (COPD) defined by different criteria by age, and place of residence. The dark grey bar represents ‘rural’

Scatter plot of the % change versus baseline in pulmonary function test results at a) 4 months and b) the end of the study versus the analyte concentration.

Illustration of model 2, with CFQ-R total score as the outcome.

Forest plots for randomised and cluster randomised controlled trials from Cochrane review Biomarkers as point-of-care tests to guide prescription of antibiotics.

Changes in median exhaled CO levels from baseline to 12 weeks in quitters (n=183) and continuous smokers (n=94). Changes in median exhaled CO levels from.

Changes in St. George's Respiratory Questionnaire (SGRQ) scores from baseline to 12 weeks for total samples (n=277), quitters (n=183) and continuous smokers.

Trial design. Study design schematic of the PF-ILD trial followed by a separate open-label trial (optional): part A (visits 1 through 9 over 52 weeks)

Patient-reported outcomes: proportion of patients with clinically meaningful improvements in (A) SF-36 PCS and MCS at Week 52 and Week 104*†‡ and (B) HAQ-DI.

Plots of FEV1/FEV1pred, FVC/FVCpred and FEV1/FVC against (A) BI lumen area and (B) CT-measured kyphosis angle with least squares regression lines. Plots.

Comparative receiver operating characteristic (ROC) curves and the area under the curve (AUC) in association with 30-day mortality for severity scores.

Post-bronchodilator forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) ratio in subjects aged >50 yrs. Post-bronchodilator forced expiratory.

Receiver operating characteristic curves (ROC) for the metabolites between the systemic inflammatory response syndrome (n=15) and sepsis (n=35) groups.

SGRQ total scores by (A) FVC % predicted at baseline and (B) use of supplemental oxygen at baseline. SGRQ total scores by (A) FVC % predicted at baseline.

Change in forced vital capacity (FVC) % predicted (% pred) per week from baseline in the CAPACITY 004 and 006 study comparing pirfenidone (2403 mg·day−1)

Mean change from baseline in 6MWD in (A) Chinese patients with PAH in PATENT-1 and (B) Chinese patients with CTEPH in CHEST-1. Mean change from baseline.

Worse eDiary scores are associated the more rescue inhaler usage and reduced step counts over both an individual day and 3-week summary period. Worse eDiary.

Stavros V. Konstantinides et al. JACC 2017;69:

Prevalence of air flow obstruction (age-adjusted) by (A) lower limit of normal of forced expiratory ratio versus self-reported doctor diagnosis and (B)

(A) Energy and (B) protein intake/day during hospitalisation and in follow-up. (A) Energy and (B) protein intake/day during hospitalisation and in follow-up.

Stepwise management. Stepwise management. Antibiotics are used to treat exacerbations that present with an acute detrioration (usually over several days)

All microorganism strains isolated from the sputum during the study period. All microorganism strains isolated from the sputum during the study period.

Receiver operating characteristic ROC curve of Lung Clearance Index (LCI)1/40, LCI1/30, LCI1/20, LCI1/10 and inverse forced expiratory volume in 1 s %

Screening test accuracy of the final risk score at a threshold of ≥2

Reclined functional residual capacity (FRC) predicts cough inspired volume, which in turn predicts cough flow. Reclined functional residual capacity (FRC)

Illustration of model 1, with CFQ-R total score as the outcome.

HFNC off is compared with HFNC 30 L/min and HFNC 50 L/min for tidal volume. HFNC off is compared with HFNC 30 L/min and HFNC 50 L/min for tidal volume.

Number of patients treated at clinics that followed up fewer than 10 patients (2013–2016) or 20 patients (2012) and proportion of patients followed up.

FIM total score by study visit (ITT population).

In-room sound levels recorded by sound metres on decibels on the A-weighted (dBA) and decibels on the C-weighted scale (dBC) scales. In-room sound levels.

Vitamin D3 increased ASL antimicrobial activity in non-smokers.

Comparison of reclined functional residual capacity (FRC) in stroke patients and controls. Comparison of reclined functional residual capacity (FRC) in.

Secondary outcomes: changes from baseline per treatment group (tolerance population). Secondary outcomes: changes from baseline per treatment group (tolerance.

Glycemic control in Hispanic and non-Hispanic patients during the SWITCH 2 trial. Glycemic control in Hispanic and non-Hispanic patients during the SWITCH.

Chronic obstructive pulmonary disease (COPD) prevalence (postbronchodilator FEV1/FVC (forced expiratory volume in 1 s/forced vital capacity)

Directed acyclic graph showing potential confounders of the association between maternal total iron status in pregnancy (exposure of interest) and offspring.

Odds ratio (95% confidence intervals) of reporting respiratory symptoms in patients with treated hypothyroidism or inflammatory bowel disease (IBD) compared.

Mean change from baseline in percentage predicted forced vital capacity (FVC) in the a) phase III CAPACITY [27] and b) ASCEND [14] studies. #: n=174; ¶:

Effects of reslizumab on lung function (forced expiratory volume in 1 s; FEV1) in Global Initiative for Asthma (GINA) Step 4 and 5 patients. Effects of.

Study protocol. Study protocol. (A) Patients were randomly allocated to placebo or amitriptyline treatment for four weeks. At the end of the month there.

ICU length of stay comparing LTV and HTV mechanical ventilation in adult patients with ARDS. ARDS, acute respiratory distress syndrome; HTV, higher tidal.

Assessment of patients with possible occupational asthma.

Presentation transcript:

Modelled mean (SEM) observed forced vital capacity (FVC) volume change from baseline (mL) over time by dose intensity (>90%, ≤90%), based on actual dose (modified intention-to-treat population). Modelled mean (SEM) observed forced vital capacity (FVC) volume change from baseline (mL) over time by dose intensity (>90%, ≤90%), based on actual dose (modified intention-to-treat population). No imputation for missing values and deaths. Months 3, 6, 9 and 12 correspond to weeks 12, 24, 36 and 48 for CAPACITY (004 and 006) studies and weeks 13, 26, 39 and 52 for ASCEND (016), respectively. The annual rate of decline was estimated from the linear mixed-effects model comparing pirfenidone with placebo for each of the dose intensity groups (>90%, ≤90%), with change from baseline as the outcome variable. Study (CAPACITY 004 and 006 and ASCEND 016), treatment, sex, age and height were evaluated as fixed effects, and patient and assessment time were evaluated as random effects in an unstructured variance–covariance matrix. Steven D Nathan et al. BMJ Open Resp Res 2018;5:e000323 ©2018 by British Thoracic Society